2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines

Cancer Biology and Therapy

Volumn 3, Issue 9, 2004, Pages 864-870

  Dwarakanath, B S ^a   Khaitan, Divya ^a   Ravindranath, T ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

2 deoxy D glucose; Camptothecin; Chemotherapy; Etoposide; Topoisomerases

Indexed keywords

CAMPTOTHECIN; DEOXYGLUCOSE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; GLUCOSE; HOE 33342; ADENOSINE TRIPHOSPHATE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; ENZYME INHIBITOR; RADIOSENSITIZING AGENT;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOGENETICS; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GLIOMA; HUMAN; HUMAN CELL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; BRAIN TUMOR; CELL CULTURE; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZIMIDAZOLES; BRAIN NEOPLASMS; CAMPTOTHECIN; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; DEOXYGLUCOSE; DNA DAMAGE; DNA TOPOISOMERASES; DRUG INTERACTIONS; ENZYME INHIBITORS; ETOPOSIDE; GLIOMA; HUMANS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 17644376230     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.9.1040     Document Type: Article

References (64)

1. Hande KR. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochem Biophys Acta 1998; 173:1400.
2. Champoux JJ. DNA topoisomerases: Structure, function and mechanism. Ann Rev Biochem 2000; 369-413.
3. Chen AY, Liu LF. DNA topoisomerases: Essential enzymes and lethal targets. Ann Rev Pharmacol Toxicol 1994; 34:191-218.
4. Wang JC. DNA topoisomerases. Ann Rev Biochem 1996; 65:635-92.
5. Osheroff N. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: Inhibition of DNA religation by etoposide. Biochemistry 1980; 28:6157.
6. Fry AM, Chresta CM, Davies SM, Walker MC, Harris AL, Hartley JA, et al. Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res 1991; 51:6592-5.
7. Ross W, Rowe T, Glisson B, Yalowich J, Long L. Role of topoisomerase II in mediating epipodophyllotoxin induced DNA cleavage. Cancer Res 1984; 44:5857.
8. Smit EF, Carney DN, Harford P, Sleijfer DT, Postmus PE. A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 1989; 44:631.
9. Sinha BK. Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs 1995; 49:11-9.
10. Han Z, Wei W, Dunawy S, Darnowski JW, Calabresi P, Sedivy J, et al. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 2002; 277:7154-60.
11. Dwarakanath BS, Zolzer F, Chandna S, Bauch T, Adhikari JS, Muller MS, et al. Heterogeneity in 2-deoxy-D-glucose induced modifications in energetic and radiation responses of human tumor cell lines. Int J Radiation Oncology Biology Phy 2001; 50:1051-61.
12. Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 1987; 235:1495-8.
13. Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H. Over-expression of facultative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990; 170:223-30.
14. Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 1996; 56:1164-7.
15. Rempel A, Bannasch P, Mayer D. Difference in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim Biophys Acta 1994; 1219:660-8.
16. Shim H, Dolde C, Lewis BC. c-Myc transactivation of LDH-A: Implication for tumor metabolism and growth. Proc Natl Acad Sci 1997; 94:6658-63.
17. Weber G. Enzymology of cancer cells new. N Eng J Med 1977; 296:541-51.
18. Dichiro G, Brooks RA, Patronas NT. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 1984; 15:5138-46.
19. Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 1998; 263:13655-62.
20. Merall NW, Plevin R, Gould GW. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell signal 1993; 5:667-75.
21. Padma MV, Said S, Jacobs M. Prediction of pathology and survival by FDG PET in gliomas. J Neuro-oncol 2003; 64:227-37.
22. Dang CC, Semenza GL. Oncogenic alterations of metabolism. Elsevier Science 1999; 68-72.
23. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the warburg effect in carcinogenesis. J Biol Chem 2002; 28:23111-5.
24. Jain VK, Holtz W, Pohlit Purohit SC. Inhibition of unscheduled DNA synthesis and repair of potentially lethal x-ray damage by 2-deoxy-D-glucose in yeast. Int J Radiat Biol 1977; 32:175-80.
25. Jain VK, Gupta I, Lata K. Energetic of cellular repair processes in a respiratory deficient mutant of yeast. Radiation Res 1982; 92:463-73.
26. Jain VK, Kalia VK, Sharma R, Maharajan V, Menon M. Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human tumor cells. Int J Radiat Oncol Biol Phys 1985; 11:943-50.
27. Dwarakanath BS, Jain VK. Energy linked modification of the radiation response in a human cerebral glioma cell line. Int J Radiat Oncol Boil Phys 1989; 17:1033-40.
28. Jain VK, Porschen E, Feinendegen LE. Optimization of cancer therapy. Par II-effects of combining 2-deoxy-D-glucose treatment with gamma irradiation on sarcoma-180. Ind J Exp Biol 1977; 15:714-8.
29. Purohit SC, Pohlit W. Experimental evaluation of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG) as a possible adjuvant to radiotherapy of tumors. I. Kinetics of growth and survival of Ehrlich ascites tumor cells (EATC) in vitro and growth of solid tumors after 2-DG and x-irradiation. Int J Radiat Oncology Biol Phys 1982; 8:495-9.
30. Dwarakanath BS, Jain VK. Modification of the radiation-induced damage by 2-deoxy-D-Glucose in organ cultures of cerebral gliomas. Int J Radioat Oncol Biol Phys 1987; 13:741-6.
31. Jha, Pohlit W. Effects of 2-deoxy-D-glucose on DNA double strand break repair, cell survival and energy metabolism in euoxic Ehrlich ascites tumor cells. Int J Radiat Biol 1992; 62:409-15.
32. Dwarakanath BS, Zolzer F, Adhikari JS. 2-deoxy-D-Glucose induced modifications of proliferation kinetics and radiation-induced division delay in human tumor cells in vitro. Recent aspects of cellular and applied radiobiology. In: Schineeweiss FHA, Sharan RN, eds. Germany: Forschungszentrum Julich GmbH 1999.
33. Jain V, Pohlit W. Influence of energy metabolism on the repair of x-ray damage in living cells. III. Effect of 2-deoxy-D-glucose on the liquid holding reactivation in yeast. Biophysik 1973; 10:137.
34. Dwarakanath BS, Mathew T, Lazar Jain V. Experimental and clinical studies to improve the radiotherapy of human brain tumors. Biomedicine 2000; 20:73-86.
35. Dwarakanath BS, Khaitan D. Inhibitors of topoisomerase poisons as anticancer drugs; Problems and prospects. International conference on emerging trends in cancer research. Delhi: Jawaharlal Nehru University, 2002.
36. Dwarakanath BS. Energy metabolism and repair of radiation-induced damage in brain tumors. Bangalore: Bangalore University, PhD Thesis 1988.
37. 1 block and p53 status in six human cell lines. Radiother Oncol 1995; 37:20-8.
38. Yanagihara K, Nii M, Numoto K, Kamiya, Tauchi HS, Sawada, et al. Radiation induced apoptotic cell death in human gastric epithelial tumour cells: Corelation between mitotic death and apoptosis. Int J Radiat Biol 1995; 77:677-85.
39. Dwarakanath BS, Adhikari JS, Jain V. Hematoporphyrin derivative potentiate the radiosensitive effects of 2-DG in cancer cells. Int J Radiation Oncol Biol Phys 1999; 43:1125-33.
40. Roti, JL, Wright WD. Visualization of DNA loops in nucleoids from HeLa cells: Assays for DNA damage and repair. Cytometry 1987; 8:461-7.
41. Shailja S, Dwarkanath BS, Adhikari JS, Chandna S, Mathew TL. Inhibition of UV induced DNA repair by minor groove DNA ligand H-342 in human tumor cell lines. XXV All India Cell Biology Conference 2001; 70.
42. Johnston A, Mcnerney R. Changes in topoisomerase I activity after irradiation of lymphoid cells. Bioscience Reports 1985; 5:907-12.
43. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L, et al. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Biol 1993; 64:583-91.
44. Tomida A, Yun J, Tsuruo T. Glucose regulated stresses induce resistance to camptothecin in human cancer cells. Int J Cancer 1996; 68:391.
45. Gillano V, Ikhitar AM, Malinovski OV. The effects of inhibitors of DNA topoisomerase II on the radiosensitivity, repair and conformational changes in the chromatin in mammalian cells. Radiobiologia 1993; 33:189.
46. Lambet JM, Fernandes Double J. Topoisomerase II cleavable complex formation within DNA loop domains. Biochem Pharmacol 2000; 60:101.
47. Nittis, Wang JC. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc Natl Acad Sci USA 1988; 85:7501-5.
48. Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985; 260:14873.
49. Hsiang YH, Lihou MG, Liu LF. Arrest of replication forks in drugs stabilized topoisomerase I DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 1989; 49:5077.
50. Yang X, Darling J, McMillan T. Radiosensitivity, recovery and dose rate effect in three human glioma cell lines. Radiother Oncol 1990; 19:49-56.
51. Mao Y, Sun M, Desai SD, Liu LF. SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase mediated DNA damage. Proc Natl Acad Sci SA 2000; 97:4046-51.
52. Andoh T, Ishii K, Suzuki Y, Ikegami Y, Kusumoki Y, Kokada TT. Characterization of a mammalian mutant with a camptothecin resistant DNA topoisomerase I. Proc Natl Acad Sci USA 1987; 84:5565-9.
53. Dwarakanath BS, Mathew TL. Approaches for improving cancer chemotherapy using topoisomerase inhibitors. XXII Annual Conference of Indian Association of Biomedical Scientists, at IABMS Chennai, 2001.
54. Jeggo PA, Caldecott KW, Pidsley S, Banks GR. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res 1989; 49:7057-63.
55. Frankeberg-Schwager M, Harbich R, Frankenberg D, Jain V. 2-deoxy-D-glucose inhibits rejoining of radiation induced DNA double strand breaks in years. Int J Radiat Biol 1992; 61:185-90.
56. Jha B, Pohlit W. Effects of 2-deoxy-D-glucose on DNA double strand break repair, cell survival and energy metabolism in euoxic ehrlich ascites tumor cells. Int J Radiat Biol 1992; 62:409-15.
57. Dwarakanath BS, Jain VK. Enhancement of the radiation damage by 2-deoxy-D-glucose in organ cultures of brain tumors. Indian J Med Res 1985; 82:266-8.
58. cdc2/Cyclin B1. Cancer Res 1992; 52:1823-9.
59. Waterhouse N, Kumar S, Song Q, Strike P, Sparrow L, Dreyfuss G, et al. Heteronuclear ribonucleoproteins C1 and C2 components of the spliceosome are specific targets of interleukin 1 beta-converting enzyme-like proteases in apoptosis. The American Society for Biochemistry and Molecular Biology, Inc., 1996:271:29335-41.
60. Cornforth MN, Goodwin EH. Transmission of radiation-induced acentric chromosomal fragments to micronuclei in normal human fibroblasts. Radiat Res 1991; 126:210-7.
61. Eischen Christine M, Kottke Timothy J, Martins Luis M, Basi Guriqbal S, Tung Jay S, Earnshaw William C, et al. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 1997; 90:935-43.
62. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: Role of ATP dependent transporters. Nature 2002; 2:48-58.
63. Gupta S, Mathur R, Dwarakanath BS. Modification of etoposide induced toxicity by 2-DG in murine tumors. Euro J Oncol 2002.
64. Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli BA, et al. Improving cancer radiotherapy with 2-deoxy-D-glucose: Phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys 1996; 35:103-11.